APTIOM
Identification of Aptiom
| No description |
Google image searchProduct monograph
Active ingredient
eslicarbazepine acetate, 200 MG
DIN: 02426862
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: SUMITOMO PHARMA CANADA, INC.
Date: 30-MAY-2024
ATC:
- N03 — ANTIEPILEPTICS (ATC, ATC/DDD, )
- N03A — ANTIEPILEPTICS (ATC, ATC/DDD)
- N03AF — Carboxamide derivatives (ATC, ATC/DDD)
- N03AF04 — ESLICARBAZEPINE (ATC/DDD)
